Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Most Accessed Articles






Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery

, 2021; 22(6): 631-655.

Anuraj Nayarisseri*, Ravina Khandelwal, Poonam Tanwar, Maddala Madhavi, Diksha Sharma, Garima Thakur, Alejandro Speck-Planche and Sanjeev Kumar Singh*


DOI: 10.2174/1389450122999210104205732


TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease

, 2021; 22(7): 760-769.

Federica Furfaro*, Ludovico Alfarone, Daniela Gilardi, Carmen Correale, Mariangela Allocca, Gionata Fiorino, Marjorie Argollo, Alessandra Zilli, Eirini Zacharopoulou, Laura Loy, Giulia Roda and Silvio Danese


DOI: 10.2174/1389450122999210120205607



COVID-19 and Renal Diseases: An Update

, 2021; 22(1): 52-67.

Letícia Bitencourt, Ana Luisa Pedrosa, Stephanie Bruna Camilo Soares de Brito, Ana Cláudia Fontoura Fróes, Sarah Tayná de Carvalho, Giulio Gori Fonseca, Guilherme Costa Ferreira, Pollyanna Faria Fradico and Ana Cristina Simões e Silva*


DOI: 10.2174/1389450121999201013151300



Thrombosis in IBD in the Era of JAK Inhibition

, 2021; 22(1): 126-136.

Virginia Solitano, Gionata Fiorino, Ferdinando D’Amico, Laurent Peyrin-Biroulet and Silvio Danese*


DOI: 10.2174/1389450121666200902164240






Curcumin and its Multi-target Function Against Pain and Inflammation: An Update of Pre-clinical Data

, 2021; 22(6): 656-671.

Shaikh Jamal Uddin*, Md. Fahim Hasan, Mohasana Afroz, Dipto Kumer Sarker, Razina Rouf, Muhammad Torequl Islam, Jamil A. Shilpi and Mohammad S. Mubarak*


DOI: 10.2174/1389450121666200925150022


New Approaches for the Treatment of Chagas Disease

, 2021; 22(7): 835-841.

Ramendra Pati Pandey*, Marilda Savoia Nascimento, Catrin E. Moore, V. Samuel Raj, Jorge Kalil and Edecio Cunha-Neto


DOI: 10.2174/1389450121999201124122643


Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities

, 2021; 22(5): 488-504.

Muhammad Adnan, Azhar Rasul*, Ghulam Hussain, Muhammad Ajmal Shah*, Iqra Sarfraz, Bushra Nageen, Ammara Riaz, Rida Khalid, Muhammad Asrar, Zeliha Selamoglu, Şevki Adem and Satyajit D. Sarker


DOI: 10.2174/1389450121999201013154542


Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion

, 2021; 22(2): 192-201.

Upinder Kaur, Sankha Shubhra Chakrabarti*, Bisweswar Ojha, Bhairav Kumar Pathak, Amit Singh, Luciano Saso and Sasanka Chakrabarti


DOI: 10.2174/1389450121666200924113243



Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog